{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:15:39Z","timestamp":1761765339201},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T00:00:00Z","timestamp":1284595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11033-010-0282-0","type":"journal-article","created":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T08:31:40Z","timestamp":1284539500000},"page":"1697-1702","source":"Crossref","is-referenced-by-count":36,"title":["Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel"],"prefix":"10.1007","volume":"38","author":[{"given":"Bo","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Chun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,16]]},"reference":[{"key":"282_CR1","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s11033-008-9396-z","volume":"36","author":"Z Chen","year":"2009","unstructured":"Chen Z, Ma G, Qian Q, Yao Y, Feng Y, Tang C (2009) Toll-like receptor 8 polymorphism and coronary artery disease. Mol Biol Rep 36:1897\u20131901","journal-title":"Mol Biol Rep"},{"key":"282_CR2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s11033-008-9439-5","volume":"36","author":"A Var","year":"2009","unstructured":"Var A, Ut\u00fck O, Ak\u00e7ali S, Sanlidag T, Uyanik BS, Din\u00e7 G (2009) Impact of hemostatic gene single point mutations in patients with non-diabetic coronary artery disease. Mol Biol Rep 36:2235\u20132243","journal-title":"Mol Biol Rep"},{"key":"282_CR3","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s11033-009-9666-4","volume":"37","author":"A Vaisi-Raygani","year":"2010","unstructured":"Vaisi-Raygani A, Rahimi Z, Tavilani H, Pourmotabbed T (2010) Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients. Mol Biol Rep 37:2083\u20132091","journal-title":"Mol Biol Rep"},{"key":"282_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","volume":"117","author":"SB King III","year":"2008","unstructured":"King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, Feldman TE, Kern MJ, O\u2019Neill WW, Schaff HV, Whitlow PL, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW (2008) 2007 Focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 117:261\u2013295","journal-title":"Circulation"},{"key":"282_CR5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","volume":"45","author":"VL Serebruany","year":"2005","unstructured":"Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ (2005) Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 45:246\u2013251","journal-title":"J Am Coll Cardiol"},{"key":"282_CR6","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","volume":"109","author":"S Matetzky","year":"2004","unstructured":"Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109:3171\u20133175","journal-title":"Circulation"},{"key":"282_CR7","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2006.06.065","volume":"48","author":"W Hochholzer","year":"2006","unstructured":"Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina CM, Ferenc M, Gick M, Caputo A, B\u00fcttner HJ, Neumann FJ (2006) Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 48:1742\u20131750","journal-title":"J Am Coll Cardiol"},{"key":"282_CR8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1124\/dmd.105.007989","volume":"34","author":"JL Rehmel","year":"2006","unstructured":"Rehmel JL, Eckstein JA, Farid NA, Heim JB, Kasper SC, Kurihara A, Wrighton SA, Ring BJ (2006) Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450. Drug Metab Dispos 34:600\u2013607","journal-title":"Drug Metab Dispos"},{"key":"282_CR9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ahj.2007.12.034","volume":"155","author":"P Gladding","year":"2008","unstructured":"Gladding P, Webster M, Ormiston J, Olsen S, White H (2008) Antiplatelet drug nonresponsiveness. Am Heart J 155:591\u2013599","journal-title":"Am Heart J"},{"key":"282_CR10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jcin.2008.09.008","volume":"1","author":"P Gladding","year":"2008","unstructured":"Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, Scott D, Gunes A, Dahl ML (2008) The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial. JACC Cardiovasc Interv 1:620\u2013627","journal-title":"JACC Cardiovasc Interv"},{"key":"282_CR11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1253\/circj.72.1165","volume":"72","author":"LA Malek","year":"2008","unstructured":"Malek LA, Kisiel B, Spiewak M, Grabowski M, Filipiak KJ, Kostrzewa G, Huczek Z, Ploski R, Opolski G (2008) Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel. Circ J 72:1165\u20131169","journal-title":"Circ J"},{"key":"282_CR12","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","volume":"51","author":"D Trenk","year":"2008","unstructured":"Trenk D, Hochholzer W, Fromm MF, Chialda LE, Pahl A, Valina CM, Stratz C, Schmiebusch P, Bestehorn HP, B\u00fcttner HJ, Neumann FJ (2008) Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol 51:1925\u20131934","journal-title":"J Am Coll Cardiol"},{"key":"282_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(08)61845-0","volume":"373","author":"JP Collet","year":"2009","unstructured":"Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, Payot L, Brugier D, Cayla G, Beygui F, Bensimon G, Funck-Brentano C, Montalescot G (2009) Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 373:309\u2013317","journal-title":"Lancet"},{"key":"282_CR14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.amjcard.2008.11.048","volume":"103","author":"B Giusti","year":"2009","unstructured":"Giusti B, Gori AM, Marcucci R, Saracini C, Sestini I, Paniccia R, Buonamici P, Antoniucci D, Abbate R, Gensini GF (2009) Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. Am J Cardiol 103:806\u2013811","journal-title":"Am J Cardiol"},{"key":"282_CR15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","volume":"360","author":"JL Mega","year":"2009","unstructured":"Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS (2009) Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 360:354\u2013362","journal-title":"N Engl J Med"},{"key":"282_CR16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/eurheartj\/ehp041","volume":"30","author":"D Sibbing","year":"2009","unstructured":"Sibbing D, Stegherr J, Latz W, Koch W, Mehilli J, D\u00f6rrler K, Morath T, Sch\u00f6mig A, Kastrati A, von Beckerath N (2009) Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention. Eur Heart J 30:916\u2013922","journal-title":"Eur Heart J"},{"key":"282_CR17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","volume":"360","author":"T Simon","year":"2009","unstructured":"Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, M\u00e9neveau N, Steg PG, Ferri\u00e8res J, Danchin N, Becquemont L, French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators (2009) Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 360:363\u2013375","journal-title":"N Engl J Med"},{"key":"282_CR18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","volume":"302","author":"AR Shuldiner","year":"2009","unstructured":"Shuldiner AR, O\u2019Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, Pollin TI, Post W, Parsa A, Mitchell BD, Faraday N, Herzog W, Gurbel PA (2009) Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA 302:849\u2013857","journal-title":"JAMA"},{"key":"282_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2008.01105.x","volume":"75","author":"G Feher","year":"2009","unstructured":"Feher G, Feher A, Pusch G, Lupkovics G, Szapary L, Papp E (2009) The genetics of antiplatelet drug resistance. Clin Genet 75:1\u201318","journal-title":"Clin Genet"},{"key":"282_CR20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","volume":"119","author":"R Marcucci","year":"2009","unstructured":"Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF (2009) Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Circulation 119:237\u2013242","journal-title":"Circulation"},{"key":"282_CR21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/0091270009332433","volume":"49","author":"NF Ford","year":"2009","unstructured":"Ford NF (2009) Clopidogrel resistance: pharmacokinetic or pharmacogenetic? J Clin Pharmacol 49:506\u2013512","journal-title":"J Clin Pharmacol"},{"key":"282_CR22","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1538-7836.2007.02775.x","volume":"5","author":"JT Brandt","year":"2007","unstructured":"Brandt JT, Close SL, Iturria SJ, Payne CD, Farid NA, Ernest CS 2nd, Lachno DR, Salazar D, Winters KJ (2007) Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel. J Thromb Haemost 5:2429\u20132436","journal-title":"J Thromb Haemost"},{"key":"282_CR23","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehp157","volume":"30","author":"C Varenhorst","year":"2009","unstructured":"Varenhorst C, James S, Erlinge D, Brandt JT, Braun OO, Man M, Siegbahn A, Walker J, Wallentin L, Winters KJ, Close SL (2009) Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease. Eur Heart J 30:1744\u20131752","journal-title":"Eur Heart J"},{"key":"282_CR24","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","volume":"49","author":"DJ Angiolillo","year":"2007","unstructured":"Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA (2007) Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 49:1505\u20131516","journal-title":"J Am Coll Cardiol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-010-0282-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-010-0282-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-010-0282-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:03:00Z","timestamp":1559343780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-010-0282-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,16]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1007\/s11033-010-0282-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,16]]}}}